#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunoglobulin G4 related disease Retinopathy of prematurity Central nervous system neoplasm Li-Fraumeni syndrome Selective polysaccharide antibody deficiency Sjogren's syndrome Rett syndrome Breast cancer Mucopolysaccharidosis II Von Willebrand's disease Porphyria non-acute Sexually transmitted disease Adenocarcinoma pancreas Inborn error of metabolism Intracranial germ cell tumour More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Basic Information Alagille syndrome Hyperoxaluria – Trials in Disease Retinoblastoma – Basic Information Idiopathic pulmonary fibrosis – Treatment Haemophilia A with anti factor VIII – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Proteus syndrome – Trials in Disease Ornithine transcarbamoylase deficiency Pituitary-dependent Cushing’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zanubrutinib Ramipril Cdr132L Sodium CIRTUVIVINT TRIACYLGLYCEROL LIPASE Art6043 Montelukast Sodium Aavanc80-3'Hotof IPN01195 Rupatadine Treosulfan Lacosamide Vemircopan Eplerenone Dermatophagoides Farinae Stiripentol Xanomeline Tartrate Tretinoin Codeine Phosphate Peboctocogene Camaparvovec More therapies…

    Learn about Your Condition

    Hypoaesthesia Meniscus operation Urinary incontinence Mucopolysaccharidosis III Ocular melanoma Diminished ovarian reserve Primary hyperthyroidism Varicella Connective tissue disorder Palpitations Viral myocarditis Elderly Osteomyelitis acute Lymphoedema Morning sickness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Pancreas Removal and Islet Cell Transplant for Patients with Pancreatic Cancer at High Risk of Post-Surgery Leaks

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Autologous Pancreatic Islets
    Germany

  • Study of Activated NK Cells for Treating Sarcomas in Children, Adolescents, and Young Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line
    Spain

  • Study on MDMA-Assisted Therapy for Patients with Treatment-Resistant PTSD

    Recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Midomafetamine Hydrochloride
    The Netherlands

  • Study on BI-1808 and Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bi-1808
    • Pembrolizumab
    Denmark Hungary Spain Sweden

  • Study on Solifenacin, Mirabegron, and Their Combination for Treating Overactive Bladder and Daytime Urinary Incontinence in Children Aged 5 to 14 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Incontinence
    • Urinary incontinence
    Investigated Drugs:
    • Mirabegron
    • Solifenacin Succinate
    Denmark

  • Study on Rivaroxaban for Patients with End-Stage Renal Disease on Hemodialysis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • Rivaroxaban
    France
Previous Page
1 … 470 471 472 473 474 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!